Israeli defense stocks plunge on Tel Aviv Exchange amid global de-escalation

Aris down 11%, NextVision 10%, Third Eye 10%; Israir drops 7.6%, El Al 1.7% as investors expect foreign airlines to resume Israel flights

The stocks of Israeli defense companies sharply fell Monday amid signs of easing geopolitical tensions, while pharmaceutical giant Teva also dropped following a major policy announcement by U.S. President Donald Trump, cutting drug prices.
Shares of Israeli defense firms, which have surged to record highs in recent months, plunged as investors reacted to a series of international developments that may reduce near-term demand for advanced military technologies. These include Trump’s visit to the Middle East, the reported end of hostilities between nuclear-armed rivals India and Pakistan, and an anticipated summit between Russian President Vladimir Putin and Ukrainian President Volodymyr Zelensky.
2 View gallery
הבורסה לניירות ערך בתל אביב
הבורסה לניירות ערך בתל אביב
Tel Aviv Stock Exchange
(Photo: Orel Cohen)
Among the hardest hit: Aris Industries slid about 11%, NextVision dropped 10%, Aerodrome declined 9%, Third Eye fell 10% and Elbit Systems shed approximately 5.2%.
Travel and tourism stocks, which recently soared after international carriers canceled flights to Israel, also pulled back. Israir dropped 7.6% and El Al fell 1.7%, amid speculation that foreign airlines could soon resume service to the country.
The benchmark indices — TA-35, TA-90 and TA-125 — were all down less than 1%.
Get the Ynetnews app on your smartphone: Google Play: https://bit.ly/4eJ37pE | Apple App Store: https://bit.ly/3ZL7iNv
Trading opened with a delay under a mechanism known as an "English opening" after Teva Pharmaceuticals plummeted more than 9% in pre-market trading, pulling down the indices. The slump followed Trump’s late-night announcement that he will sign an executive order to tie U.S. prescription drug prices to prices in other countries — a move analysts say could cut prices by as much as 80%.
2 View gallery
מטה טבע
מטה טבע
Teva headquarters
(Photo: Sivan Faraj)
Despite the initial delay, trading resumed with early gains of more than 1% in the major indices, though those later faded, and some turned slightly negative. Teva shares were last down about 5.5%.
Teva's downturn follows a string of losses in recent days. The stock fell 4.8% on Sunday and another 6.3% on Friday on Wall Street. Analysts had attributed the earlier drops to profit-taking after the company posted strong earnings and announced plans to lay off nearly 3,000 employees.
Meanwhile, U.S. futures pointed sharply higher: Nasdaq futures surged nearly 4%, the S&P 500 gained 2.8%, and the Dow Jones Industrial Average rose 2.2%. Gold prices fell 2.8% to $3,251 per ounce following the announcement of a preliminary U.S.–China tariff agreement, which was disclosed by the Biden administration Sunday and detailed further on Monday.
<< Follow Ynetnews on Facebook | Twitter | Instagram | Telegram >>
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""